Inventiva

IVANasdaq France Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$1.134 B

$4.80 +3.00%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

193,236,978

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#152SavaraSVRA$1.19B
#153Corvus PharmaceuticalsCRVS$1.17B
#154InventivaIVA$1.13B
#155Alto NeuroscienceANRO$1.11B
#156Lexicon PharmaceuticalsLXRX$1.10B

Where these numbers come from

Share counts and financials for Inventiva are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.